Health Care & Life Sciences » Pharmaceuticals | Dong-A ST Co. Ltd.

Dong-A ST Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
65,709
37,550
47,506
9,335
5,396
8,009
Depreciation, Depletion & Amortization
20,401
24,919
23,979
21,519
21,724
20,036
Other Funds
1
4,302
1,984
-
-
39,623
Funds from Operations
36,629
63,978
77,479
20,686
44,152
67,667
Changes in Working Capital
15,839
11,526
44,268
25,497
2,283
20,204
Net Operating Cash Flow
20,790
75,504
33,211
4,811
46,434
47,463
Capital Expenditures
35,983
32,232
32,227
22,141
11,592
Sale of Fixed Assets & Businesses
658
341
30,430
69,310
2,487
Purchase/Sale of Investments
4,632
984
20,309
1,545
9,067
Net Investing Cash Flow
30,708
30,527
18,628
43,970
4,303
Cash Dividends Paid - Total
-
2,214
5,773
8,031
4,220
Issuance/Reduction of Debt, Net
93
109,859
83,330
82,684
114,088
Net Financing Cash Flow
698
111,946
58,850
56,170
118,308
Net Change in Cash
63,015
161,267
2,728
10,290
94,692
Free Cash Flow
52,957
45,947
4,935
25,442
35,706
Net Assets from Acquisitions
-
-
-
2,309
-
Other Sources
551
380
600
1,609
14,028
Change in Capital Stock
606
-
28,270
34,545
-
Exchange Rate Effect
10,820
4,344
9,738
6,722
18,516
Other Uses
566
-
483
954
158

About Dong-A ST Co.

View Profile
Address
64 Cheonhodae-ro
Seoul SL 02587
Korea, Republic Of
Employees -
Website http://www.donga-st.com
Updated 07/08/2019
Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products includes medicines for gastric mucous membrane protection, antihistanminic agetnts, ischemic improvements, antithrombotic, functional digestion, hyperlipemia cure, growth hormone, antipeptic ulcer cure, cerebral metabolic, high blood pressure, and others. The company was founded on March 4, 2013 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.